feed,title,long_url,short_url
TheStreet,Curis Drops; Lower Dose of Leukemia Drug to Reach Phase 2 Study,https://www.thestreet.com/investing/curis-drops-lower-dose-leukemia-drug-to-reach-phase-2-trial,https://j.mp/3zn4PJu
TheStreet,"5 Top Stock Gainers for Friday: Novan, Magnachip, Vaxart",https://www.thestreet.com/investing/novan-magnachip-vaxart-nio-stock-gainers-friday,https://j.mp/3wkmLCW
